XNCR
Xencor, Inc.
NASDAQ · Healthcare · Biotechnology · US
$26.61
−0.04%Margins
Gross margin
43.3%
EBITDA margin
-117.7%
EBIT margin
-205.8%
Net margin
-155.6%
FCF margin
-198.4%
-32.5%
Return on equity
-22.5%
Return on assets
-38.0%
Return on invested capital
0.14x
Asset turnover
-$205.8M
Cash from operations
$6.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026